
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
LUPNc1:NS | NSE | INR | Delayed | |
LUPNc2:NS | NSE | INR | Delayed | |
LUPNc3:NS | NSE | INR | Delayed |
Gilead Sciences Inc. (GILD) announced it reached settlement agreements with three generic drug manufacturers to resolve patent litigation over Biktarvy, the company’s HIV treatment medication. The...
Investing.com - Investec has upgraded Lupin (BOM:LPC) from Hold to Buy and raised its price target to INR2,265.00 from INR2,100.00, citing the company’s positioning to capitalize on the GLP-1...
Lupin Limited (500257, NSE: LUPIN) received U.S. Food and Drug Administration approval for its risperidone extended-release injectable suspension in 25 mg, 37.5 mg, and 50 mg single-dose vials. The...
Investing.com-- India’s Sun Pharmaceutical Industries (NSE:SUN) and Lupin Ltd (NSE:LUPN) are seeking regulatory approval to develop affordable anti-obesity pills as the country faces a mounting...
Investing.com - BofA Securities has upgraded Lupin (NSE:LUPN) (NSE:LPC) from Underperform to Neutral while raising its price target to INR1,970.00 from INR1,930.00, citing a more favorable...
Investing.com - Jefferies has upgraded Lupin (NSE:LUPN) (BOM:LPC) stock rating from Hold to Buy while raising its price target to INR2,250.00 from INR2,200.00. The upgrade follows Lupin's...
Investing.com - Morgan Stanley (NYSE:MS) has initiated coverage on Lupin (NSE:LUPN) (BOM:LPC) with an Equalweight rating and a price target of INR2,096.00, citing the company's ongoing...
On Friday, JPMorgan analyst Bansi Desai adjusted the price target for Lupin (NSE:LUPN) (LPC:IN) to INR 2,450.00, a decrease from the previous INR 2,560.00, while reaffirming an Overweight rating...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review